About us

Alvion is a science oriented pharmaceutical company developing and manufacturing non infringing generic medicines in Europe. Collaborating with state of the art R&D centers in EU, Alvion is a private and independent company focusing in R&D, IP, Quality, Regulatory and manufacturing of generic and added value medicines, delivering an exceptional track record in the global pharmaceutical market supplying millions of patients.

By developing a best-in-class international pharmaceutical company, Alvion is launching a wide portfolio of products and services across Europe, MENA, Canada, Australia, South Africa and Latin America partnering with some of the most well-known multinational pharmaceuticals companies. Operating from both Athens, Greece and Galway, Ireland, Alvion group is an Intellectual Property p o w e r h o u s e offering non infringing medicines and high level of services to more than ninety pharmaceutical companies in a b2b level. Out licensing of its proprietaries and supplying these medicines is the core business of the group, aiming to become the next unicorn in its industry in Europe.

Through its global reach and its offices in Ireland and Durban, South Africa, the group is marketing indirectly an number of complex products via the marketing leaders across fifty plus markets, targeting always to be first to market, offering in a number of products vertical integration via its co-developments partners at a competitive cost.